SCHEMBL21946887

SCHEMBL21946887

CC(C)(C)OC(=O)N1CC(c2ccc(Nc3nc(N4CCCCC4)cnc3C(N)=O)cc2)C1

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 17/20 0.64
▸ LCK P06239 16/20 0.64
▸ EGFR P00533 12/20 0.64
▸ BTK Q06187 13/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23484941 0.93 JAK3 (0.71) JAK3LCKEGFRBTK
SCHEMBL21946363 0.92 JAK3 (0.72) JAK3LCKEGFRBTK
SCHEMBL30448210 0.92 JAK3 (0.72) JAK3LCKEGFRBTK
SCHEMBL26970114 0.92 JAK3 (0.65) JAK3LCKEGFRBTK
SCHEMBL21946318 0.87 LCK (0.59) JAK3LCKEGFRBTK
SCHEMBL31039906 0.87 LCK (0.59) JAK3LCKEGFRBTK
SCHEMBL21855164 0.87 LCK (0.59) JAK3LCKEGFRBTK
SCHEMBL24927490 0.87 LCK (0.59) JAK3LCKEGFRBTK
SCHEMBL21946361 0.85 JAK3 (0.68) JAK3LCKEGFRBTK
SCHEMBL30448986 0.85 JAK3 (0.68) JAK3LCKEGFRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081450-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-04-23 — — WO disclosed
Send feedback